| 000 | 01533 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515104021.0 | ||
| 264 | 0 | _c20080930 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a1304-0855 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzarpira, Negar | |
| 245 | 0 | 0 |
_aMethylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant. _h[electronic resource] |
| 260 |
_bExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _cDec 2007 |
||
| 300 |
_a693-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xenzymology |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 |
_aMethylenetetrahydrofolate Reductase (NADPH2) _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRamzi, Mani | |
| 700 | 1 | _aAghdaie, Mahdokht Hossein | |
| 700 | 1 | _aDaraie, Masumeh | |
| 700 | 1 | _aGeramizadeh, Bita | |
| 773 | 0 |
_tExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _gvol. 5 _gno. 2 _gp. 693-7 |
|
| 999 |
_c17702510 _d17702510 |
||